Pharmacological characterisation of [(px)phe 4]nociceptin(1-13)nh 2 analogues: 2. In vivo studies

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 365, Issue 6, 2002, Pages 450-456

  Rizzi, Anna ^a,b,c,d   Salis, Maria ^a,b,c,d   Ciccocioppo, Roberto ^a,b,c,d   Marzola, Giuliano ^a,b,c,d   Bigoni, Raffaella ^a,b,c,d   Guerrini, Remo ^a,b,c,d   Massi, Maurizio ^a,b,c,d   Madeddu, Paolo ^a,b,c,d   Salvadori, Severo ^a,b,c,d   Regoli, Domenico ^a,b,c,d   Calo, Girolamo ^a,b,c,d  

^a UNIVERSITY OF FERRARA   (Italy)

^b National Laboratory   (Italy)

^c UNIVERSITY OF SASSARI   (Italy)

^d UNIVERSITY OF CAMERINO   (Italy)

Author keywords

(pF)Phe 4 NC(1 13)NH 2; Mouse blood pressure; Mouse heart rate; Mouse locomotor activity; Mouse tail withdrawal; Nociceptin orphanin FQ; OP 4 receptor; Rat food intake

Indexed keywords

NOCICEPTIN DERIVATIVE; NOCICEPTIN[1-13][1 PHENYLALANINE N]AMIDE; NOCICEPTIN[1-13][4 PHENYLALANINE(FLUORINE)]AMIDE; NOCICEPTIN[1-13][4 PHENYLALANINE(NITROGEN DIOXIDE)]AMIDE; NOCICEPTIN[1-13]AMIDE; OPIATE ANTAGONIST; UNCLASSIFIED DRUG; NOCICEPTIN (1 13) AMIDE; NOCICEPTIN (1-13) AMIDE; NOCICEPTIN RECEPTOR; OPIATE PEPTIDE; OPIATE RECEPTOR; PEPTIDE FRAGMENT;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG SELECTIVITY; HEART RATE; HEMODYNAMIC MONITORING; IN VIVO STUDY; LOCOMOTION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; EATING; HEMODYNAMICS; MOTOR ACTIVITY; PAIN ASSESSMENT; PHYSIOLOGY; RAT; STRUCTURE ACTIVITY RELATION; WISTAR RAT;

ANIMAL; COMPARATIVE STUDY; EATING; HEMODYNAMICS; MALE; MICE; MOTOR ACTIVITY; OPIOID PEPTIDES; PAIN MEASUREMENT; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECEPTORS, OPIOID; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T; ANIMALS; HEMODYNAMIC PROCESSES;

EID: 0035987107     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-002-0549-7     Document Type: Article

References (19)

1. 4]nociceptin(1-13)amide analogues. 1. In vitro studies
2. Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay
3. 2, a new selective nociceptin receptor antagonist
4. Pharmacology of nociceptin and its receptor: A novel therapeutic target
5. Nociceptin/orphanin FQ receptor ligands
6. Binding and in vitro activities of peptides with high affinity for the nociceptin/orphanin FQ receptor, ORL1
7. Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide
8. A new selective antagonist of the nociceptin receptor
9. Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): Identification of highly potent agonists of the nociceptin/orphanin FQ receptor
10. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: Anxiolytic profile in the rat
11. International Union of Pharmacology Committee on receptor nomenclature and drug classification. XI Recommendations on terms and symbols in quantitative pharmacology
12. Intracerebroventricular injections in mice. Some methodological refinements
13. Cardiovascular effects of nociceptin in unanesthetized mice
14. Highly potent nociceptin analog containing the Arg-Lys triple repeat
15. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist
16. Pharmacological characterization of the nociceptin receptor mediating hyperphagia: Identification of a selective antagonist
17. Characterization of the locomotor activity-inhibiting effect of nociceptin/orphanin FQ in mice
18. Studies of the cardiovascular effects of nociceptin and related peptides
19. 4-Aminoquinolines: Novel nociceptin antagonists with analgesic activity